Vivtex
PrivateLast Round
Accelerator
May 9, 2024
Total Funding Raised
$1.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivtex operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in May 2024.
Vivtex is a biotechnology company that operates a healthcare platform for drug development using robotic technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivtex Comparables
Compare Vivtex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| i2O Therapeutics | 87% | |
| Cyprumed GmbH | 80% | |
| Biograil | 79% |
For institutional investors. Book with your work email.
Vivtex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 9, 2024 | ||||
| Convertible Debt | Aug 19, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivtex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Elizabeth Elting Venture Fund | Accelerator |
| Endless Frontier Labs | Accelerator |
| Portal Innovations | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 40% QoQ, from 20 to 28 employees.
- Jul 19, 2026
Grew 20% QoQ, from 20 to 24 employees.
For institutional investors. Book with your work email.
Vivtex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivtex's valuation, stock price, and market status.
Is Vivtex a public or private company?
Vivtex is a private company.
What is the current stock price of Vivtex?
Vivtex is a private company, so its shares have no public market price. Caplight tracks Vivtex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivtex worth (valuation)?
Valuation information for Vivtex is not publicly available.
Can I buy Vivtex stock?
Vivtex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivtex's last funding round?
Vivtex's most recent funding round was Accelerator on May 9, 2024.
Who are the main investors in Vivtex?
Key investors in Vivtex include The Elizabeth Elting Venture Fund, Endless Frontier Labs, Portal Innovations.
Will Vivtex IPO soon?
No public IPO plans have been announced for Vivtex.
How can I track Vivtex secondary market activity?
Caplight tracks bids, offers, and trades in Vivtex's shares on secondary markets.